General Information of the Compound
| Compound ID |
CP0541894
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-N-[(2R)-1-[[(4S)-2-(2-amino-2-oxoethyl)-3-oxo-4,5-dihydro-1H-benzo[i][2]benzazepin-4-yl]amino]-1-oxopropan-2-yl]-3-(4-hydroxy-2,6-dimethylphenyl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H35N5O5
|
||||||||||||||||||
| Molecular Weight |
545.64
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H](NC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C)C(=O)N[C@H]1Cc2ccc3ccccc3c2CN(CC(N)=O)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H35N5O5/c1-16-10-21(36)11-17(2)23(16)13-25(31)29(39)33-18(3)28(38)34-26-12-20-9-8-19-6-4-5-7-22(19)24(20)14-35(30(26)40)15-27(32)37/h4-11,18,25-26,36H,12-15,31H2,1-3H3,(H2,32,37)(H,33,39)(H,34,38)/t18-,25+,26+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YORAQSHAPRUNHY-LROUJFHJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor